1. Home
  2. FLGT vs THQ Comparison

FLGT vs THQ Comparison

Compare FLGT & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • THQ
  • Stock Information
  • Founded
  • FLGT 2011
  • THQ 2014
  • Country
  • FLGT United States
  • THQ United States
  • Employees
  • FLGT N/A
  • THQ N/A
  • Industry
  • FLGT Medical Specialities
  • THQ Finance Companies
  • Sector
  • FLGT Health Care
  • THQ Finance
  • Exchange
  • FLGT Nasdaq
  • THQ Nasdaq
  • Market Cap
  • FLGT 697.3M
  • THQ 714.6M
  • IPO Year
  • FLGT 2016
  • THQ N/A
  • Fundamental
  • Price
  • FLGT $23.00
  • THQ $18.06
  • Analyst Decision
  • FLGT Buy
  • THQ
  • Analyst Count
  • FLGT 3
  • THQ 0
  • Target Price
  • FLGT $25.33
  • THQ N/A
  • AVG Volume (30 Days)
  • FLGT 228.6K
  • THQ 158.9K
  • Earning Date
  • FLGT 11-07-2025
  • THQ 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • THQ 7.53%
  • EPS Growth
  • FLGT N/A
  • THQ N/A
  • EPS
  • FLGT N/A
  • THQ N/A
  • Revenue
  • FLGT $303,223,000.00
  • THQ N/A
  • Revenue This Year
  • FLGT $15.19
  • THQ N/A
  • Revenue Next Year
  • FLGT $10.58
  • THQ N/A
  • P/E Ratio
  • FLGT N/A
  • THQ N/A
  • Revenue Growth
  • FLGT 4.31
  • THQ N/A
  • 52 Week Low
  • FLGT $14.57
  • THQ $15.29
  • 52 Week High
  • FLGT $23.57
  • THQ $20.38
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 60.31
  • THQ 69.14
  • Support Level
  • FLGT $22.05
  • THQ $16.78
  • Resistance Level
  • FLGT $23.57
  • THQ $18.30
  • Average True Range (ATR)
  • FLGT 0.68
  • THQ 0.28
  • MACD
  • FLGT 0.02
  • THQ 0.10
  • Stochastic Oscillator
  • FLGT 74.94
  • THQ 83.55

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.

Share on Social Networks: